上海莼试生物技术有限公司
   
菜单 Close 公司首页 公司介绍 公司动态 产品展厅 证书荣誉 联系方式 在线留言
您当前的位置: 网站首页 > 产品展厅 >抗体 >环指蛋白75抗体费用
产品展厅
环指蛋白75抗体费用
  • 品牌:上海莼试
  • 产地:进口、国产
  • 货号:CS11033
  • 发布日期: 2019-01-07
  • 更新日期: 2024-11-27
产品详请
产地 进口、国产
品牌 上海莼试
保存条件 Store at -20 °C
货号 CS11033
应用范围 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
CAS编号
抗体名 Anti-ROC1/RNF75
克隆性
靶点 详见说明书
适应物种 详见说明书
形态 详见说明书
宿主 详见说明书
亚型 IgG
标识物 详见说明书
浓度 1mg/1ml%
免疫原 KLH conjugated synthetic peptide derived from human ROC1/RNF75

产品订购信息:
英文名称  Anti-ROC1/RNF75 

中文名称   环指蛋白75抗体费用 

      E3 ubiquitin-protein ligase RBX1; MGC13357; MGC1481; Protein ZYP; Rbx 1; Rbx1; RBX1_HUMAN; Regulator of Cullins 1; Ring box 1; RING box protein 1; RING finger protein 75; RING finger protein; RING-box protein 1; Ringbox protein 1; RNF 75; RNF75; ROC 1; ZYP protein.


       1mg/1ml

  0.2ml/200μg

抗体来源   Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Cow 

产品类型   一抗  

研究领域    细胞生物 免疫学 表观遗传学

蛋白分子量  predicted molecular weight: 12kDa

       Lyophilized or Liquid

 KLH conjugated synthetic peptide derived from human ROC1/RNF75 

       IgG

纯化方法   affinity purified by Protein A

   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

环指蛋白75抗体费用 产品应用    WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200

(石蜡切片需做抗原修复) 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 E3 ubiquitin ligase component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins, including proteins involved in cell cycle progression, signal transduction, transcription and transcription-coupled nucleotide excision repair. The functional specificity of the E3 ubiquitin-protein ligase complexes depends on the variable substrate recognition components. As a component of the CSA complex promotes the ubiquitination of ERCC6 resulting in proteasomal degradation. Through the RING-type zinc finger, seems to recruit the E2 ubiquitination enzyme, like CDC34, to the complex and brings it into close proximity to the substrate. Probably also stimulates CDC34 autoubiquitination. May be required for histone H3 and histone H4 ubiquitination in response to ultraviolet and for subsequent DNA repair. Promotes the neddylation of CUL1, CUL2, CUL4 and CUL4 via its interaction with UBE2M.

Function : E3 ubiquitin ligase component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins, including proteins involved in cell cycle progression, signal transduction, transcription and transcription-coupled nucleotide excision repair. The functional specificity of the E3 ubiquitin-protein ligase complexes depends on the variable substrate recognition components. As a component of the CSA complex promotes the ubiquitination of ERCC6 resulting in proteasomal degradation. Through the RING-type zinc finger, seems to recruit the E2 ubiquitination enzyme, like CDC34, to the complex and brings it into close proximity to the substrate. Probably also stimulates CDC34 autoubiquitination. May be required for histone H3 and histone H4 ubiquitination in response to ultraviolet and for subsequent DNA repair. Promotes the neddylation of CUL1, CUL2, CUL4 and CUL4 via its interaction with UBE2M. Involved in the ubiquitination of KEAP1, ENC1 and KLHL41.

Subunit : Part of a SCF complex consisting of CUL1, RBX1, SKP1 and SKP2. Part of a SCF-like complex consisting of CUL7, RBX1, SKP1 and FBXW8. Part of CBC(VHL) complexes with elongin BC complex (TCEB1 and TCEB2), CUL2 or CUL5 and VHL. Part of the CSA complex (DCX(ERCC8) complex), a DCX E3 ubiquitin-protein ligase complex containing ERCC8, RBX1, DDB1 and CUL4A; the CSA complex interacts with RNA polymerase II; upon UV irradiation it interacts with the COP9 signalosome and preferentially with the hyperphosphorylated form of RNA polymerase II. Part of multisubunit E3 ubiquitin ligase complexes with elongin BC complex (TCEB1 and TCEB2), CUL2 and MED8; elongin BC complex (TCEB1 and TCEB2), CUL5 and MUF1. Part of multisubunit complexes with elongin BC complex (TCEB1 and TCEB2), elongin A/TCEB3 or SOCS1 or WSB1 and CUL5. Interacts directly with CUL1 and probably also with CUL2, CUL3, CUL4A, CUL4B, CUL5 and CUL7. Probably interacts with CDC34. Interacts with COPS6. Component of the DCX DET1-COP1 ubiquitin ligase complex at least composed of RBX1, DET1, DDB1, CUL4A and COP1. Part of an E3 ligase complex composed of RBX1, DDB1, DDB2 and CUL4A or CUL4B. Interacts with UBE2M. Part of a SCF complex consisting of CUL1, FBXO3, RBX1 and SKP1; this complex interacts with PML via FBXO3. Interacts with human adenovirus early E1A protein; this interaction inhibits RBX1-CUL1-dependent elongation reaction of ubiquitin chains by the SCF(FBW7) complex. Component of the SCF(Cyclin F) complex consisting of CUL1, RBX1, SKP1 and CCNF. Identified in a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complex together with HINT1 and CDC34. Component of multiple BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complexes formed of CUL3, RBX1 and a variable BTB domain-containing protein. Part of the BCR(ENC1) complex containing ENC1. Part of the BCR(GAN) complex containing GAN. Part of the BCR(KLHL41) complex containing KLHL41. Part of the BCR(KEAP1) complex containing KEAP1.

Subcellular Location : Cytoplasm. Nucleus.

Tissue Specificity : Widely expressed.

Similarity : Belongs to the RING-box family.

Contains 1 RING-type zinc finger.

Database links : UniProtKB/Swiss-Prot: P62877.1

GRB2/ASH peptide 生长因子受体结合蛋白2抗原Multi-class antibodies规格: 0.5mg

Oct4 Oct4 鼠单抗 (FITC) Human

Rhesus antibody Rh phospho-CstF64(Ser498) 磷酸化细胞分裂相关蛋白CSTF64抗体 规格 0.1ml

染色液 100ml 自产

ZNF704 英文名称: 锌指蛋白704抗体 0.2ml

DCUN1D2 英文名称: DCN1样蛋白2抗体 0.2ml

Oct4 Oct4 鼠单抗 (FITC) Human

ATEXPA10 peptide 植物扩张蛋白ATEXPA10(拟南芥)抗原Multi-class antibodies规格: 0.5mg

抗磷酸化Bcl-xL(pSer62)蛋白抗体 Anti-phospho-Bcl-xL 0.1ml

Rhesus antibody Rh phospho-EGFR (Ser1166) 磷酸化表皮生长因子受体抗体 规格 0.1ml

DMEM高糖 10×1L Gibco

ZNF740 英文名称: 锌指蛋白740抗体 0.2ml

DYRK3 英文名称: 双特异性酪酸磷酸化调节激酶3抗体 0.2ml

抗磷酸化Bcl-xL(pSer62)蛋白抗体 Anti-phospho-Bcl-xL 0.1ml

phospho-ZCWCC1 (Ser739) 英文名称: 磷酸化ZCWCC1抗体 0.1ml

DSPP 英文名称: 牙本质磷蛋白抗体 0.1ml

APP淀粉样肽前体蛋白抗体 Anti-APP/Amyloid beta A4 0.1ml

Anti-AFP/HRP 辣根过氧化物酶标记鼠抗人甲胎蛋白单克隆抗体(检测)IgGMulti-class antibodies规格: 0.2ml

Rhesus antibody Rh Phospho-eNOS(Thr495) 磷酸化合成酶3抗体(内皮型) 规格 0.1ml

Nadrin peptide 发育调节蛋白多肽抗原Multi-class antibodies规格: 0.5mg

TNFSF8 Protein Rat 重组大鼠 CD153 / CD30L / TNFSF8 蛋白 (Fc 标签)

EC9706

LIF Others Mouse 小鼠 LIF 人细胞裂解液 (阳性对照)

SW620人细胞 SW620 human colon cancer cells L-15+10%FBS

人上皮细胞;Hep-2

人胚胎绒毛细胞(HAF)(1×106 ) 细胞名称 种属

CL-0430RS1(大鼠皮肤成纤维样细胞)5×106cells/瓶×2

IL22RA1 Others Canine 狗 IL22RA1 / IL22R 人细胞裂解液 (阳性对照)

人食道上皮细胞RNAHEEpiC miRNA5 μg

兔间变表皮鳞株;VX2 细胞,22RV1细胞 MDCK superdome细胞,狗肾细胞隆突型

人永生化淋巴细胞;CNLMG-B5537LC

HA Others H3N2 甲型 H3N2 (A/Aichi/2/1968) 血凝素HA1 (Hemagglutinin) 人细胞裂解液 (阳性对照)

环指蛋白75抗体费用 TNFSF8 Protein Rat 重组大鼠 CD153 / CD30L / TNFSF8 蛋白 (Fc 标签)

EC9706

LIF Others Mouse 小鼠 LIF 人细胞裂解液 (阳性对照)

SW620人细胞 SW620 human colon cancer cells L-15+10%FBS

人上皮细胞;Hep-2

人胚胎绒毛细胞(HAF)(1×106 ) 细胞名称 种属

抗体的生物素化标记实验要点:

1. 环指蛋白75抗体费用 如在反应混合液中有叠氮钠或游离氨基存在,会抑制标记反应。因此,蛋白质在反应前要对 0.1mol/L碳酸氢钠缓冲液或0.5mol/L硼酸缓冲液充分透析;

2.所用的NHSB及待生物素化蛋白质之间的分子比按蛋白质表面的ε-氨基的密度会有所不同,选择不当则影响标记的效率,应先用几个不同的分子比来筛选最适条件;

3.NHSB量过量也是不利的,抗原的结合位点可能因此被封闭,导致抗体失活;

4.由于抗体的氨基不易接近可能造成生物素化不足,此时可加入去污剂如 Triton x-100, Tween20等;

5.当游离ε-氨基(赖氨酸残基的氨基)存在于抗体的抗原结合位点时,或位于酶的催化位点时,生物素化会降低或损伤抗体蛋白的结合力或活性;

6.生物素还可能与不同的功能基团,如羰基、氨基、巯基、异咪唑基及苯酚基,也可与糖基共价结合;

7.交联反应后,应充分透析,否则,残余的生物素会对生物素化抗体与亲和素的结合产生竞争作用;

8.在细胞的荧光标记实验中,中和亲和素的本底低,但由于链霉亲和素含有少量正电荷,故对某些细胞可导致高本底。

抗体的鉴定:

1环指蛋白75抗体费用 抗体的效价鉴定:不管是用于诊断还是用于,制备抗体的目的都是要求较高效价。不同的抗原制备的抗体,要求的效价不一。鉴定效价的方法很多,包括有试管凝集反应,琼脂扩散试验,酶联免疫吸附试验等。常用的抗原所制备的抗体一般都有约成的鉴定效价的方法,以资比较。如制备抗抗体的效价,一般就采用琼脂扩散试验来鉴定。

2)抗体的特异性鉴定:抗体的特异性是指与相应抗原或近似抗原物质的识别能力。抗体的特异性高,它的识别能力就强。衡量特异性通常以交叉反应率来表示。交叉反应率可用竞争抑制试验测定。以不同浓度抗原和近似抗原分别做竞争抑制曲线,计算各自的结合率,求出各自在IC50时的浓度,并按公式计算交叉反应率。 

如果所用抗原浓度IC50浓度为pg/,而一些近似抗原物质的IC50浓度几乎是无穷大时,表示这一抗血清与其他抗原物质的交叉反应率近似为0,即该血清的特异性较好。

3)抗体亲和力:是指抗体和抗原结合的牢固程度。亲和力的高低是由抗原分子的大小,抗体分子的结合位点与抗原决定簇之间立体构型的合适度决定的。有助于维持抗原抗体复合物稳定的分子间力有氢键,疏水键,侧链相反电荷基因的库仑力,范德华力和空间斥力。亲和力常以亲和常数K表示,K的单位是L/mol。抗体亲和力的测定对抗体的筛选,确定抗体的用途,验证抗体的均一性等均有重要意义。

 


联系方式
手机:13585831301
Q Q: